Antibody-Dependent Cellular Cytotoxicity Riiia and Mediate Γ

Total Page:16

File Type:pdf, Size:1020Kb

Antibody-Dependent Cellular Cytotoxicity Riiia and Mediate Γ Effector Memory αβ T Lymphocytes Can Express Fc γRIIIa and Mediate Antibody-Dependent Cellular Cytotoxicity This information is current as Béatrice Clémenceau, Régine Vivien, Mathilde Berthomé, of September 27, 2021. Nelly Robillard, Richard Garand, Géraldine Gallot, Solène Vollant and Henri Vié J Immunol 2008; 180:5327-5334; ; doi: 10.4049/jimmunol.180.8.5327 http://www.jimmunol.org/content/180/8/5327 Downloaded from References This article cites 43 articles, 21 of which you can access for free at: http://www.jimmunol.org/content/180/8/5327.full#ref-list-1 http://www.jimmunol.org/ Why The JI? Submit online. • Rapid Reviews! 30 days* from submission to initial decision • No Triage! Every submission reviewed by practicing scientists • Fast Publication! 4 weeks from acceptance to publication by guest on September 27, 2021 *average Subscription Information about subscribing to The Journal of Immunology is online at: http://jimmunol.org/subscription Permissions Submit copyright permission requests at: http://www.aai.org/About/Publications/JI/copyright.html Email Alerts Receive free email-alerts when new articles cite this article. Sign up at: http://jimmunol.org/alerts The Journal of Immunology is published twice each month by The American Association of Immunologists, Inc., 1451 Rockville Pike, Suite 650, Rockville, MD 20852 Copyright © 2008 by The American Association of Immunologists All rights reserved. Print ISSN: 0022-1767 Online ISSN: 1550-6606. The Journal of Immunology Effector Memory ␣␤ T Lymphocytes Can Express Fc␥RIIIa and Mediate Antibody-Dependent Cellular Cytotoxicity1 Be´atrice Cle´menceau,*† Re´gine Vivien,*† Mathilde Berthome´,*† Nelly Robillard,‡ Richard Garand,‡ Ge´raldine Gallot,*† Sole`ne Vollant,*† and Henri Vie´2*† Human memory T cells are comprised of distinct populations with different homing potential and effector functions: central memory T cells that mount recall responses to Ags in secondary lymphoid organs, and effector memory T cells that confer immediate protection in peripheral tissues. In the present study we demonstrate that a proportion of effector memory T cells express Fc␥RIIIa (CD16), are perforin positive, and directly mediate Ab-dependent cytotoxicity ex vivo. This particular ␣␤ T lymphocyte subset has the morphology of large granular lymphocytes, increases proportionately in vivo during reactive lympho- cytosis, and can be detected in vitro among EBV-specific T lymphocytes after stimulation with EBV Ags. Consequently, during a normal immune response, amplification of these effector memory T lymphocytes that are capable of Ab-dependent cytotoxicity Downloaded from may have beneficial or harmful consequences depending on the presence of pathogen- or tissue-specific Abs, respectively. The Journal of Immunology, 2008, 180: 5327–5334. he vast majority of cells that express the IgG FcR re- tionated T cell population with respect to reactivity with anti-CD3, sponsible for Ab-dependent cellular cytotoxicity -CD4, and -CD5 mAb (OKT3, OKT4, and OKT5, respectively) 3 T (ADCC ;Fc␥RIIIa or CD16) belong to the innate im- while the T␥-enriched population contained, in fact, only 10–20% http://www.jimmunol.org/ mune system (1). These include monocytes/macrophages and of T cells as defined by OKT3 (10–12). The authors of these stud- NK cells. Among PBMC, it is assumed that essentially all ies concluded appropriately that the T␥ cells included a small pop- ADCC activity is mediated by NK cells. Nevertheless, the ex- ulation reactive with OKT3 and a large population reactive with istence of T lymphocytes bearing FcRs for Ig has long been OKM1, most likely corresponding to NK cells (10). Based on recognized, although data concerning ADCC mediated by T these findings, it was unclear whether ADCC attributed to the T␥ lymphocytes are rare. subset was mediated by the CD3- (non-T) NK fraction or the small Indeed, in the past, initial attempts to discriminate subsets proportion of CD3ϩ T cells that express FcR for IgG. Later on, as among T lymphocytes relied on the use of either antisera or dif- stated above, essentially all NK activity present among PBMC was by guest on September 27, 2021 ferential FcR binding. Using the latter approach, two human T cell attributed to the NK population. In the early 1980s, several mAb subsets could be separated: those capable of binding the Fc portion were produced (anti-Leu-11, VEP 13, B73.1, and 3G8) that spe- ␮ of IgM (T ) and those capable of binding the Fc portion of IgG cifically reacted with the IgG FcR responsible for ADCC ␥ (T ) (2–6). However, at that time, discrimination between differ- (Fc␥RIIIa, CD16) (13–16) and the presence in most individuals of ent lymphocyte subsets was limited because the separation tech- cells with the CD3ϩCD16ϩ phenotype was confirmed (14, 17, 18). nique relied on density-gradient centrifugation of the subpopula- These cells usually comprise Ͻ2% of total PBL, with rare ex- tions of lymphocytes that form rosettes with erythrocytes coated ceptions (18). In addition, it was specified that human T lym- with rabbit IgG or IgM. Using this technique, the so-called “T␥” phocytes expressing the ␥␦ TCR can express CD16 and mediate and “T␮” populations were found to display different morpholog- ADCC (19–21). In contrast, the link between the expression of ical, histochemical, and functional characteristics (7, 8). In partic- CD16 and ␣␤ TCR on T lymphocytes has remained unclear. ular, T␥ cells have been shown to mediate ADCC (9). Later on, Although cells from large granular lymphocyte leukemia have when mAb targeting lymphoid populations became available, it been shown to coexpress CD16 and an ␣␤ TCR (22, 23), the became apparent that the T␮ population was similar to the unfrac- existence of “normal” T cells harboring this phenotype has been suggested in only rare instances (24–27) and these cells have not been characterized. The present study was initiated to di- *Institut National de la Sante´et de la Recherche Me´dicale, Unite´601, Nantes, France; †l’Universite´Nantes, Nantes, France; and ‡Laboratoire d’He´matologie, Centre Hos- rectly assess the proportion, the phenotype, and the functional ϩ pitalier de l’Universite´Nantes, Nantes, France capabilities of CD16 ␣␤ TCR T cells. We demonstrate that ϩ Received for publication September 14, 2007. Accepted for publication February CD16 ␣␤ TCR T cells, which are present in small numbers in 5, 2008. all individuals 1) belong to the memory effector subset, 2) are The costs of publication of this article were defrayed in part by the payment of page perforin positive, 3) are capable of mediating ADCC immedi- charges. This article must therefore be hereby marked advertisement in accordance with 18 U.S.C. Section 1734 solely to indicate this fact. ately ex vivo, 4) increase proportionately in vivo during lym- 1 B.C. was supported by Association Francaise Contre les Myopathies. phocytosis, and 5) appear in vitro in all cultures of EBV-spe- 2 Address correspondence and reprint requests to Dr. Henri Vie´, Institut National de cific CTL. Consequently, because of their ADCC potential and la Sante´et de la Recherche Me´dicale, Unite´601, 9 Quai Moncousu, 44093 Nantes their presence among virus-specific T cells during a specific T cedex, France. E-mail address: [email protected] cell response, amplification of these CD16ϩ ␣␤ TCR effector 3 Abbreviations used in this paper: ADCC, Ab-dependent cellular cytotoxicity; memory T lymphocytes during a regular immune response may BLCL, B lymphoblastoid cell line; LGL, large granular lymphocyte. be involved in beneficial or harmful consequences depending on Copyright © 2008 by The American Association of Immunologists, Inc. 0022-1767/08/$2.00 the presence of pathogen- or tissue-specific Abs. www.jimmunol.org 5328 ADCC BY Fc␥RIIIa ␣␤ TCR T LYMPHOCYTES Materials and Methods trol. For ADCC assays, the indicated mAb was incubated with target cells Samples and cell lines for 20 min before addition of effector cells. After a 4-h incubation at 37°C, 25 ␮l of supernatant were removed from each well, mixed with 100 ␮lof PBMCs were prepared by Ficoll (PAA Laboratories) gradient centrifuga- scintillation fluid, and 51Cr activity was counted in a scintillation counter. tion of blood obtained from adult volunteers or patients with hyperlym- Each test was performed in triplicate. The results are expressed as the phocytosis that were recruited nonselectively from the Department of In- percentage of lysis, which is calculated according to the following equa- fectious Diseases (Centre Hospitalier de l’Universite´de Nantes, Nantes, tion: (experimental release Ϫ spontaneous release)/(maximal release Ϫ France). All individuals gave informed consent. EBV B lymphoblastoid spontaneous release) ϫ 100, where experimental release represents the cell lines (BLCL) were derived from PBMCs by in vitro infection using mean cpm for the target cells in the presence of effector cells, spontaneous EBV-containing culture supernatant from the Marmoset B95.8 cell line release represents the mean cpm for target cells incubated without effector purchased from the American Type Culture Collection in the presence of cells, and maximal release represents the mean cpm for target cells incu- 1 ␮g/ml cyclosporine A. The K562 cell line was cultured in complete bated with 1% Triton X-100. For the assessment of ex vivo ADCC by ϩ medium consisting of RPMI 1640 (Sigma-Aldrich), 10% heat-inactivated CD16 ␣␤ T lymphocytes, cells positively sorted by the 3G8-PC5 Ab FCS, 2 mM glutamine (Sigma-Aldrich), 100 U/ml penicillin, and 10 ␮g/ml were washed and incubated overnight in complete medium (without any streptomycin (Sigma-Aldrich). cytokines) before the functional ADCC assay. mAbs and flow cytometric analysis Statistical analysis The following mAbs and their isotype controls were used: anti-␣␤-FITC Differences between subjects with hyperlymphocytosis and healthy con- (BMA031; Serotec), anti-CCR7-PE (150503; RD Systems), anti-CD28-PE trols were analyzed using the t test. A p value of Ͻ0.05 was considered (L293), and anti-perforin-PE (␦69) (BD Biosciences).
Recommended publications
  • Human and Mouse CD Marker Handbook Human and Mouse CD Marker Key Markers - Human Key Markers - Mouse
    Welcome to More Choice CD Marker Handbook For more information, please visit: Human bdbiosciences.com/eu/go/humancdmarkers Mouse bdbiosciences.com/eu/go/mousecdmarkers Human and Mouse CD Marker Handbook Human and Mouse CD Marker Key Markers - Human Key Markers - Mouse CD3 CD3 CD (cluster of differentiation) molecules are cell surface markers T Cell CD4 CD4 useful for the identification and characterization of leukocytes. The CD CD8 CD8 nomenclature was developed and is maintained through the HLDA (Human Leukocyte Differentiation Antigens) workshop started in 1982. CD45R/B220 CD19 CD19 The goal is to provide standardization of monoclonal antibodies to B Cell CD20 CD22 (B cell activation marker) human antigens across laboratories. To characterize or “workshop” the antibodies, multiple laboratories carry out blind analyses of antibodies. These results independently validate antibody specificity. CD11c CD11c Dendritic Cell CD123 CD123 While the CD nomenclature has been developed for use with human antigens, it is applied to corresponding mouse antigens as well as antigens from other species. However, the mouse and other species NK Cell CD56 CD335 (NKp46) antibodies are not tested by HLDA. Human CD markers were reviewed by the HLDA. New CD markers Stem Cell/ CD34 CD34 were established at the HLDA9 meeting held in Barcelona in 2010. For Precursor hematopoetic stem cell only hematopoetic stem cell only additional information and CD markers please visit www.hcdm.org. Macrophage/ CD14 CD11b/ Mac-1 Monocyte CD33 Ly-71 (F4/80) CD66b Granulocyte CD66b Gr-1/Ly6G Ly6C CD41 CD41 CD61 (Integrin b3) CD61 Platelet CD9 CD62 CD62P (activated platelets) CD235a CD235a Erythrocyte Ter-119 CD146 MECA-32 CD106 CD146 Endothelial Cell CD31 CD62E (activated endothelial cells) Epithelial Cell CD236 CD326 (EPCAM1) For Research Use Only.
    [Show full text]
  • CD64-Neutrophil Expression and Stress Metabolic Patterns in Early
    Fitrolaki et al. BMC Pediatrics 2013, 13:31 http://www.biomedcentral.com/1471-2431/13/31 RESEARCH ARTICLE Open Access CD64-Neutrophil expression and stress metabolic patterns in early sepsis and severe traumatic brain injury in children Diana-Michaela Fitrolaki1, Helen Dimitriou2, Maria Kalmanti2 and George Briassoulis1* Abstract Background: Critical illness constitutes a serious derangement of metabolism. The aim of our study was to compare acute phase metabolic patterns in children with sepsis (S) or severe sepsis/septic shock (SS) to those with severe traumatic brain injury (TBI) and healthy controls (C) and to evaluate their relations to neutrophil, lymphocyte and monocyte expressions of CD64 and CD11b. Methods: Sixty children were enrolled in the study. Forty-five children with systemic inflammatory response syndrome (SIRS) were classified into three groups: TBI (n = 15), S (n = 15), and SS (n = 15). C consisted of 15 non- SIRS patients undergoing screening tests for minor elective surgery. Blood samples were collected within 6 hours after admission for flow cytometry of neutrophil, lymphocyte and monocyte expression of CD64 and CD11b (n = 60). Procalcitonin (PCT), C-reactive protein (CRP), glucose, triglycerides (TG), total cholesterol (TC), high (HDL) or low-density-lipoproteins (LDL) were also determined in all groups, and repeated on day 2 and 3 in the 3 SIRS groups (n = 150). Results: CRP, PCT and TG (p < 0.01) were significantly increased in S and SS compared to TBI and C; glucose did not differ among critically ill groups. Significantly lower were the levels of TC, LDL, and HDL in septic groups compared to C and to moderate changes in TBI (p < 0.0001) but only LDL differed between S and SS (p < 0.02).
    [Show full text]
  • Macrophages in Inflammatory Multiple Sclerosis Lesions Have An
    Vogel et al. Journal of Neuroinflammation 2013, 10:35 JOURNAL OF http://www.jneuroinflammation.com/content/10/1/35 NEUROINFLAMMATION RESEARCH Open Access Macrophages in inflammatory multiple sclerosis lesions have an intermediate activation status Daphne YS Vogel1,2, Elly JF Vereyken1, Judith E Glim1, Priscilla DAM Heijnen1, Martina Moeton1, Paul van der Valk2, Sandra Amor2,3, Charlotte E Teunissen4, Jack van Horssen1 and Christine D Dijkstra1* Abstract Background: Macrophages play a dual role in multiple sclerosis (MS) pathology. They can exert neuroprotective and growth promoting effects but also contribute to tissue damage by production of inflammatory mediators. The effector function of macrophages is determined by the way they are activated. Stimulation of monocyte-derived macrophages in vitro with interferon-γ and lipopolysaccharide results in classically activated (CA/M1) macrophages, and activation with interleukin 4 induces alternatively activated (AA/M2) macrophages. Methods: For this study, the expression of a panel of typical M1 and M2 markers on human monocyte derived M1 and M2 macrophages was analyzed using flow cytometry. This revealed that CD40 and mannose receptor (MR) were the most distinctive markers for human M1 and M2 macrophages, respectively. Using a panel of M1 and M2 markers we next examined the activation status of macrophages/microglia in MS lesions, normal appearing white matter and healthy control samples. Results: Our data show that M1 markers, including CD40, CD86, CD64 and CD32 were abundantly expressed by microglia in normal appearing white matter and by activated microglia and macrophages throughout active demyelinating MS lesions. M2 markers, such as MR and CD163 were expressed by myelin-laden macrophages in active lesions and perivascular macrophages.
    [Show full text]
  • Epha Receptors and Ephrin-A Ligands Are Upregulated by Monocytic
    Mukai et al. BMC Cell Biology (2017) 18:28 DOI 10.1186/s12860-017-0144-x RESEARCHARTICLE Open Access EphA receptors and ephrin-A ligands are upregulated by monocytic differentiation/ maturation and promote cell adhesion and protrusion formation in HL60 monocytes Midori Mukai, Norihiko Suruga, Noritaka Saeki and Kazushige Ogawa* Abstract Background: Eph signaling is known to induce contrasting cell behaviors such as promoting and inhibiting cell adhesion/ spreading by altering F-actin organization and influencing integrin activities. We have previously demonstrated that EphA2 stimulation by ephrin-A1 promotes cell adhesion through interaction with integrins and integrin ligands in two monocyte/ macrophage cell lines. Although mature mononuclear leukocytes express several members of the EphA/ephrin-A subclass, their expression has not been examined in monocytes undergoing during differentiation and maturation. Results: Using RT-PCR, we have shown that EphA2, ephrin-A1, and ephrin-A2 expression was upregulated in murine bone marrow mononuclear cells during monocyte maturation. Moreover, EphA2 and EphA4 expression was induced, and ephrin-A4 expression was upregulated, in a human promyelocytic leukemia cell line, HL60, along with monocyte differentiation toward the classical CD14++CD16− monocyte subset. Using RT-PCR and flow cytometry, we have also shown that expression levels of αL, αM, αX, and β2 integrin subunits were upregulated in HL60 cells along with monocyte differentiation while those of α4, α5, α6, and β1 subunits were unchanged. Using a cell attachment stripe assay, we have shown that stimulation by EphA as well as ephrin-A, likely promoted adhesion to an integrin ligand- coated surface in HL60 monocytes. Moreover, EphA and ephrin-A stimulation likely promoted the formation of protrusions in HL60 monocytes.
    [Show full text]
  • Direct and Antibody Dependent Cell Mediated Cytotoxicity Against Giardia Lamblia by Splenic And- Intestinal Lymphoid Cells in Mice
    Gut: first published as 10.1136/gut.27.1.73 on 1 January 1986. Downloaded from Gut, 1986, 27, 73-77 Direct and antibody dependent cell mediated cytotoxicity against Giardia lamblia by splenic and- intestinal lymphoid cells in mice S S KANWAR, N K GANGULY, B N S WALIA, AND R C MAHAJAN From the Departments ofParasitology and Paediatrics, Postgraduate Institute ofMedical Education and Research, Chandigarh, India SUMMARY Direct cytotoxicity and antibody dependent cell mediated cytotoxicity against Giardia lamblia trophozoites exhibited by splenic, intraepithelial and lamina propria lymphocyte populations isolated from G lamblia infected mice were studied. Different patterns of cytotoxicity were found. Intraepithelial lymphocytes showed a direct cytotoxic activity of 20*6±5-6% before infection. It was significantly higher on the 20th (p<0.01) and 30th (p<005) day postinfection. Lamina propria lymphocytes showed a significantly augmented level of both direct cytotoxicity and antibody dependent cell mediated cytotoxicity on the 20th and 30th postinfection days. Direct cytotoxicity by splenic lymphocytes remained unchanged during infection but antibody dependent cell mediated cytotoxicity was significantly increased. The host response to G lamblia involves the immune weighing 10-12 g were used in this study. G lamblia system. Previous exposure to this infection is known cysts were obtained from the stool of a patient and a http://gut.bmj.com/ to increase resistance to a second challenge in both fixed inoculum of 10 000 cysts/0-2 ml was prepared man and animals.1 2 Smith et al3 reported that on a sucrose gradient9 and fed to the animals.1" Five human peripheral blood monocytes/macrophages animals were killed on each of the days 0, 10, 20, are spontaneously cytotoxic for G lamblia tropho- and 30 postinfection.
    [Show full text]
  • WHO Guidance on Management of Snakebites
    GUIDELINES FOR THE MANAGEMENT OF SNAKEBITES 2nd Edition GUIDELINES FOR THE MANAGEMENT OF SNAKEBITES 2nd Edition 1. 2. 3. 4. ISBN 978-92-9022- © World Health Organization 2016 2nd Edition All rights reserved. Requests for publications, or for permission to reproduce or translate WHO publications, whether for sale or for noncommercial distribution, can be obtained from Publishing and Sales, World Health Organization, Regional Office for South-East Asia, Indraprastha Estate, Mahatma Gandhi Marg, New Delhi-110 002, India (fax: +91-11-23370197; e-mail: publications@ searo.who.int). The designations employed and the presentation of the material in this publication do not imply the expression of any opinion whatsoever on the part of the World Health Organization concerning the legal status of any country, territory, city or area or of its authorities, or concerning the delimitation of its frontiers or boundaries. Dotted lines on maps represent approximate border lines for which there may not yet be full agreement. The mention of specific companies or of certain manufacturers’ products does not imply that they are endorsed or recommended by the World Health Organization in preference to others of a similar nature that are not mentioned. Errors and omissions excepted, the names of proprietary products are distinguished by initial capital letters. All reasonable precautions have been taken by the World Health Organization to verify the information contained in this publication. However, the published material is being distributed without warranty of any kind, either expressed or implied. The responsibility for the interpretation and use of the material lies with the reader. In no event shall the World Health Organization be liable for damages arising from its use.
    [Show full text]
  • BD Horizon™ V450 Mouse Anti-Human CD64 Antibody (Cat
    BD Horizon™ Technical Data Sheet V450 Mouse anti-Human CD64 Product Information Material Number: 561202 Alternate Name: FCGR1; FcRI; Fc-gamma RI; IgG Fc Receptor I; High affinity IgG FcR1 Size: 50 tests Vol. per Test: 5 µl Clone: 10.1 Immunogen: Human rheumatoid synovial fluid cells and fibronectin-purified monocytes Isotype: Mouse (BALB/c) IgG1, κ Reactivity: QC Testing: Human Workshop: VI MA36 Storage Buffer: Aqueous buffered solution containing protein stabilizer and ≤0.09% sodium azide. Description The 10.1 monoclonal antibody specifically binds to CD64, a 75 kDa type I transmembrane glycoprotein that is a high affinity receptor for human IgG (FcγRI), especially the IgG1 and IgG3 subclasses. CD64 is expressed on monocytes, macrophages, dendritic cells, granulocytes activated with interferon-gamma and early myeloid lineage cells. CD64 associates with a signaling FcRγ homodimer to form the functional high affinity FcγRI complex. CD64 functions in both innate and adaptive immune responses and mediates endocytosis, phagocytosis, antibody-dependent cellular toxicity, cytokine release and superoxide generation. The antibody is conjugated to BD Horizon™ V450, which has been developed for use in multicolor flow cytometry experiments and is available exclusively from BD Biosciences. It is excited by the Violet laser Ex max of 406 nm and has an Em Max at 450 nm. Conjugates with BD Horizon™ V450 can be used in place of Pacific Blue™ conjugates. Flow cytometric analysis of CD64 expression on human peripheral blood monocytes. Whole blood was stained with BD Horizon™ V450 Mouse Anti-Human CD64 antibody (Cat. No. 561202; solid line histogram) or with a BD Horizon™ V450 Mouse IgG1, κ Isotype Control (Cat.
    [Show full text]
  • Slan Monocytes and Macrophages Mediate CD20-Dependent B-Cell
    Published OnlineFirst May 10, 2018; DOI: 10.1158/0008-5472.CAN-17-2344 Cancer Tumor Biology and Immunology Research slanþ Monocytes and Macrophages Mediate CD20-Dependent B-cell Lymphoma Elimination via ADCC and ADCP William Vermi1,2, Alessandra Micheletti3, Giulia Finotti3, Cristina Tecchio4, Federica Calzetti3, Sara Costa3, Mattia Bugatti1, Stefano Calza5, Claudio Agostinelli6, Stefano Pileri7, Piera Balzarini1, Alessandra Tucci8, Giuseppe Rossi8, Lara Furlani4, Giuseppe Todeschini4, Alberto Zamo9, Fabio Facchetti1, Luisa Lorenzi1, Silvia Lonardi1, and Marco A. Cassatella3 Abstract þ Terminal tissue differentiation and function of slan monocytes in cancer þ + + is largely unexplored. Our recent studies demonstrated that slan mono- slan monocyte slan macrophage cytes differentiate into a distinct subset of dendritic cells (DC) in human CD16A þ tonsils and that slan cells colonize metastatic carcinoma-draining lymph CD32 nodes. Herein, we report by retrospective analysis of multi-institutional þ CD16A CD64 cohorts that slan cells infiltrate various types of non-Hodgkin lymphomas = RTX (NHL), particularly the diffuse large B-cell lymphoma (DLBCL) group, CD20 þ CD20 including the most aggressive, nodal and extranodal, forms. Nodal slan cells displayed features of either immature DC or macrophages, in the latter case ingesting tumor cells and apoptotic bodies. We also found in patients þ þ with DLBCL that peripheral blood slan monocytes, but not CD14 monocytes, increased in number and displayed highly efficient rituxi- Lymphoma cell Lymphoma cell mab-mediated antibody-dependent cellular cytotoxicity, almost equivalent + RTX þ to that exerted by NK cells. Notably, slan monocytes cultured in condi- tioned medium from nodal DLBCL (DCM) acquired a macrophage-like + RTX phenotype, retained CD16 expression, and became very efficient in ritux- imab-mediated antibody-dependent cellular phagocytosis (ADCP).
    [Show full text]
  • Increased Adhesive Potential of Antiphospholipid Syndrome Neutrophils Mediated by Beta-2 Integrin Mac-1
    DR. JASON S KNIGHT (Orcid ID : 0000-0003-0995-9771) Article type : Full Length Increased adhesive potential of antiphospholipid syndrome neutrophils mediated by beta-2 integrin Mac-1 Gautam Sule, PhD1*; William J. Kelley, MSE2*; Kelsey Gockman, BS1; Srilakshmi Yalavarthi, MS1; Andrew P. Vreede, MD1; Alison L. Banka, MSE2; Paula L. Bockenstedt, MD3; Omolola Eniola-Adefeso, PhD2╪; and Jason S. Knight, MD, PhD1╪ *G.S. and W.J.K. share first authorship ╪O.E-A. and J.S.K. share last authorship Affiliations: 1 Division of Rheumatology, Department of Internal Medicine, University of Michigan, Ann Arbor, Michigan, USA 2 Department of Chemical Engineering, University of Michigan, Ann Arbor, Michigan, USA 3 Division of Hematology/Oncology, Department of Internal Medicine, University of Michigan Medical School, Ann Arbor, Michigan, USA Correspondence: Jason S. Knight, MD, PhD 1150 W Medical CenterAuthor Manuscript Drive, Ann Arbor, MI 48109-5680 This is the author manuscript accepted for publication and has undergone full peer review but has not been through the copyediting, typesetting, pagination and proofreading process, which may lead to differences between this version and the Version of Record. Please cite this article as doi: 10.1002/ART.41057 This article is protected by copyright. All rights reserved 734-936-3257 [email protected] or Omolola Eniola-Adefeso 2800 Plymouth Road, Ann Arbor, MI 48109-2800 734-936-0856 [email protected] Running title: Neutrophil adhesion in APS Conflict of interest: None of the authors has any financial conflict of interest to disclose. ABSTRACT Objective: While the role of antiphospholipid antibodies in activating endothelial cells has been extensively studied, the impact of these antibodies on the adhesive potential of leukocytes has received less attention.
    [Show full text]
  • Development of C‑MET‑Specific Chimeric Antigen Receptor‑Engineered Natural Killer Cells with Cytotoxic Effects on Human Liver Cancer Hepg2 Cells
    MOLECULAR MEDICINE REPORTS 20: 2823-2831, 2019 Development of c‑MET‑specific chimeric antigen receptor‑engineered natural killer cells with cytotoxic effects on human liver cancer HepG2 cells BING LIU1,2*, ZHENG-ZHI LIU3*, MEI-LING ZHOU1,2, JIAN-WEI LIN1,2, XUE-MEI CHEN1,2, ZHU LI1,2, WEN-BIN GAO1, ZHEN-DONG YU4 and TAO LIU1,2 1Department of Biotherapy and Oncology; 2Public Service Platform for Cell Quality Testing and Evaluation of Shenzhen, Shenzhen Luohu People's Hospital, Shenzhen, Guangdong 518001; 3Department of Laboratory, Women and Children Health Institute of Futian, Shenzhen, Guangdong 518045; 4Central Laboratory, Peking University Shenzhen Hospital, Shenzhen, Guangdong 518036, P.R. China Received February 25, 2019; Accepted June 25, 2019 DOI: 10.3892/mmr.2019.10529 Abstract. In recent years, cellular immunotherapy has served c‑MET may be a specific and effective target for human liver an important role in the combined treatment of hepatocel- cancer cell CAR‑NK immunotherapy. Based on these results, lular carcinoma. The possibility of specific cell therapies CAR‑NK cell-based immunotherapy may provide a potential for the treatment of solid tumours has been further explored biotherapeutic approach for liver cancer treatment in the following the success of chimeric antigen receptor (CAR)-T future. cell therapy in the treatment of haematological tumours. The present study aimed to evaluate the specificity and efficiency Introduction of c-MET-targeted CAR‑NK cell immunotherapy on human liver cancer in vitro. A CAR structure that targeted and In China, the third most common cause of cancer-related recognised a c-MET antigen was constructed.
    [Show full text]
  • Cytotoxicity of Clostridium Difficile Toxin a for Human Colonie and Pancreatic Carcinoma Cell Lines1
    (CANCER RESEARCH 52, 5096-5099, September 15, 1992] Advances in Brief Cytotoxicity of Clostridium difficile Toxin A for Human Colonie and Pancreatic Carcinoma Cell Lines1 Vladimir M. Kushnaryov,2 Philip N. Redlich, J. James Sedmak,3 David M. Lyerly, Tracy D. Wilkins, and Sidney E. Grossberg Departments of Microbiology [V. M. K., J. J. S., P. N. R., S. E. GJ and Surgery [P. N. R.J, The Medical College of Wisconsin, Milwaukee, Wisconsin 53226; Department of Anaerobic Microbiology, Virginia Polytechnic Institute, Blacksburg, Virginia 24061 [D. M. L., T. D, W.J Abstract We show a selective cytopathic effect in vitro of toxin A for human cell lines derived from colonie and pancreatic carcino The use of bacterial exotoxins may constitute novel adjuncts to treat mas compared to human cells from non-gastrointestinal tract ment of gastrointestinal tract malignancies. Clostridium difficile toxin A was evaluated for its cytotoxic effect in vitro on 24 human cell lines origins. and strains including carcinomas of the colon, pancreas, prostate, lung, breast, and lymphoid malignancies, as well as nonmalignant tissues. All Materials and Methods nine colon and five pancreas cell lines were extraordinarily sensitive to the cytotoxic effect of Clostridium difficile toxin A at very low concen Toxin A. Toxin A was purified by the method of Sullivan et a/.(5). The toxin was homogeneous, as determined by polyacrylamide gel elec- trations. This effect, which occurred rapidly and was dose dependent, trophoresis and crossed immunoelectrophoresis, and was stored as a was observed in all cells of seven colon and two pancreas cell lines at filter-sterilized solution at 4°C.The level of endotoxin as measured by concentrations as low as 1-5 ng/ml (10 '- to 10 "M), whereas cells derived from other sites required 60 to greater than 500 ng/ml to achieve the Limulus lysate assay (Sigma, St.
    [Show full text]
  • Cd56dimcd16neg Cells Are Responsible for Natural Cytotoxicity Against Tumor Targets
    Leukemia (2005) 19, 835–840 & 2005 Nature Publishing Group All rights reserved 0887-6924/05 $30.00 www.nature.com/leu CD56dimCD16neg cells are responsible for natural cytotoxicity against tumor targets O Penack1, C Gentilini1, L Fischer1, AM Asemissen1, C Scheibenbogen1, E Thiel1 and L Uharek1 1Department of Hematology, Oncology, and Transfusion Medicine, Charite´-Campus Benjamin Franklin, Berlin, Germany The activation of natural killer (NK) cells leads to degranulation lysosomal-associated membrane protein-1 (CD107a). In a series and secretion of cytotoxic granula. During this process, the of experiments, it was shown that CD107a surface mobilization lytic granule membrane protein CD107a becomes detectable at 7 the cell surface. Based on this phenomenon, we have analyzed can be used to isolate and analyze cytolytic T cells ex vivo. by a novel flow cytometry-based assay, the number and Wolint et al used CD107a surface expression to study the phenotype of NK cells responding to tumor targets. Using regulation of cytolytic activity in effector T cells, effector human leukemia and lymphoma cell lines, we observed a close memory T cells and central memory T cells in response to viral correlation between CD107a surface expression and target cell targets. They found that degranulation occur with similar lysis, indicating that NK cell cytotoxicity can be assessed by kinetics in all T-cell subsets. However, degranulation of central this method. The number of degranulating NK cells was closely memory T cells was not followed by target cell lysis due to lack related to the ratio of effector and target cells and showed a 8 maximum at a ratio of 1:1.
    [Show full text]